Health
Johnson & Johnson COVID-19 vaccine candidate enters late-stage trials | News – Daily Hive
One shot, instead of two.
Pharma giant Johnson & Johnson has announced its COVID-19 vaccine candidate has entered the late-stage trials.
The pharmaceutical company said about 45,000 participants are currently enrolled in the trials, with interim data expected by the end of January 2021.
If the Johnson & Johnson vaccine candidate proves effective, the company says it will submit an emergency use authorization application to the US Food and Drug Administration (FDA) in February.
Johnson & Johnson’s study, named Ensemble, was…
-
General24 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
Noosa News13 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Noosa News13 hours agoQueen Street Mall to get a 3D digital billboard; Dutton dumps controversial plans to end flexible work; Measles alert for tourist hotspots
-
Business17 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025